Tuesday, November 26, 2024
It may sound like a broken record, but there has once again been a massive amount of options action in Nio (NIO). The Chinese electric vehicle company is up an eye-popping 1,100% so far this year, as it continues to impress investors with robust growth numbers. Perhaps even more impressive, 2 million options contracts traded […]
What a difference a vaccine makes! I am talking, of course about how my Dividend Hunter readers—the ones getting an average of 9% yields on our portfolio holdings—feel about their income-focused, stock market investments in light of the good news last Monday about an effective coronavirus vaccine. The news lit a fire under share prices […]
No, I’m not talking about the political hatred dividing our country. My concern is something deeper. If it doesn’t end, the political divide will grow worse. Wall Street On Parade (WSOP) reports JPMorgan Chase is caught once again: “…. JPMorgan Chase, the largest bank in the United States, has admitted to an unprecedented five criminal felony counts […]
Today we’re going to talk about two of the biggest stocks of 2020 which were beneficiaries of the quarantine that followed this years pandemic. These are Palenton (PTON) and Zoom (ZM). There is a case I’d like to make about why they could mean revert quite a bit lower over time.
Pfizer (PFE) and BioNTech (BNTX) were explosive earlier this week. All on news PFE just said its COVID-19 vaccine is 90% effective. “Amazing news from Pfizer with 90% efficacy. This hopefully is the beginning of the end of our fight against Covid,” Peter Boockvar, chief investment officer at Bleakley Advisory Group, said, as quoted by […]
There was great news this week about the novel coronavirus vaccine being developed by Pfizer (PFE) and Germany’s BioNTech (BNTX). The vaccine has been found to be more than 90% effective, and, if approved, it will be the first vaccine ever that uses novel mRNA technology. These results (although early and not independently vetted) far […]
It is an exciting time to be an income-focused investor. Business results are improving, yet share prices have not recovered from the February-March crash. The lack of share price recovery allows us to pick up shares of solid income stocks at excellent yields. Who wouldn’t like earning 9%, 11%, or even 15% from an investment […]
There’s a whole lot to unpack from last week. After five days of waiting for definitive numbers, media outlets have called the presidential election for Joe Biden. Senate control may take until January to decide due to two runoffs in Georgia. In other words, the market has plenty to digest. Before we talk about trading […]
Fate Therapeutics (FATE) is one of the hottest biotech stocks of the year. Since 2020, FATE ran from a low of $18.80 to a recent high of $48.20, good for a return of 156%, as compared to the iShares Nasdaq Biotech ETF (IBB), which is up 16%. From here, FATE could see higher highs ahead […]
While most eyes were on the US election, Chinese electric vehicle maker Nio (NIO) is off to the races. NIO’s stock price has climbed over 37% this past week and is up a whopping 838% for the year. The company recently announced strong October sales and better than expected growth. At least one analyst expects […]
